7.93

1.28% 0.10

Aurinia Pharmaceuticals Inc (AUPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché AUPH Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$7.83

Aprire:

$7.92

Volume 24 ore:

1.10M

Relative Volume:

0.85

Capitalizzazione di mercato:

$1.14B

Reddito:

$175.51M

Utile/perdita netta:

$-78.02M

Rapporto P/E:

-14.96

EPS:

-0.53

Flusso di cassa netto:

$-34.18M

1 W Prestazione:

+1.80%

1M Prestazione:

+2.59%

6M Prestazione:

+20.33%

1 anno Prestazione:

+38.15%

Intervallo 1D:

$7.785

$7.96

Intervallo di 1 settimana:

$7.502

$8.095

Portata 52W:

$4.71

$10.67

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Nome

Aurinia Pharmaceuticals Inc

Settore

Healthcare (1169)

Industria

Biotechnology (678)

Telefono

250-744-2487

Indirizzo

#140, 14315 - 118 AVENUE, EDMONTON, BC

Dipendente

300

Cinguettio

@AuriniaPharma

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

AUPH's Discussions on Twitter

Confronta AUPH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AUPH Aurinia Pharmaceuticals Inc	7.93	1.14B	175.51M	-78.02M	-34.18M	-0.53
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-11-04	Downgrade	Oppenheimer	Outperform → Perform
2022-05-05	Ripresa	Cantor Fitzgerald	Overweight
2021-12-10	Aggiornamento	Oppenheimer	Perform → Outperform
2021-10-28	Downgrade	Oppenheimer	Outperform → Perform
2021-01-25	Reiterato	H.C. Wainwright	Buy
2020-11-03	Reiterato	H.C. Wainwright	Buy
2020-06-17	Iniziato	BTIG Research	Buy
2020-05-05	Iniziato	Cowen	Outperform
2020-01-10	Iniziato	Jefferies	Buy
2019-12-16	Reiterato	H.C. Wainwright	Buy
2018-03-16	Reiterato	Cantor Fitzgerald	Overweight
2018-02-08	Iniziato	RBC Capital Mkts	Outperform
2017-10-30	Reiterato	H.C. Wainwright	Buy
2017-05-18	Reiterato	H.C. Wainwright	Buy
2017-04-11	Iniziato	Cantor Fitzgerald	Overweight
2017-03-22	Reiterato	FBR & Co.	Outperform
2016-12-30	Reiterato	H.C. Wainwright	Buy
2016-08-17	Reiterato	H.C. Wainwright	Buy
2016-06-30	Iniziato	H.C. Wainwright	Buy
2015-05-08	Iniziato	MLV & Co	Buy

Mostra tutto

Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie

Feb 21, 2025

(AUPH) On The My Stocks Page - Stock Traders Daily

Feb 21, 2025

Aurinia Pharmaceuticals: There's Still Time For Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Feb 21, 2025

Feb 20, 2025

Aurinia Pharmaceuticals (AUPH) to Release Earnings on Thursday - MarketBeat

Feb 20, 2025

When Will Aurinia Report Q4 Earnings? Key Date and Details for Investors - StockTitan

Feb 20, 2025

Feb 19, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Lowered to Buy at StockNews.com - MarketBeat

Feb 19, 2025

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - Simply Wall St

Feb 19, 2025

Compagnie Lombard Odier SCmA Cuts Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Feb 19, 2025

Short Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Grows By 25.5% - MarketBeat

Feb 19, 2025

Feb 18, 2025

Aurinia (AUPH) Upgraded to Buy: Here's Why - MSN

Feb 18, 2025

Head-To-Head Analysis: Aurinia Pharmaceuticals (NASDAQ:AUPH) vs. XBiotech (NASDAQ:XBIT) - Defense World

Feb 18, 2025

Feb 16, 2025

Aurinia Pharmaceuticals (AUPH) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 16, 2025

Feb 14, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Downgraded by StockNews.com to Buy - MarketBeat

Feb 14, 2025

Feb 13, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Crosses Below 50 Day Moving AverageWhat's Next? - MarketBeat

Feb 13, 2025

Aurinia Pharmaceuticals (AUPH) to Release Quarterly Earnings on Thursday - Defense World

Feb 13, 2025

Feb 11, 2025

Perhaps timely catching Aurinia Pharmaceuticals Inc (AUPH) would be a good idea - SETE News

Feb 11, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Buy Rating by StockNews.com - Defense World

Feb 11, 2025

Objective long/short (AUPH) Report - Stock Traders Daily

Feb 11, 2025

Feb 10, 2025

A Guide To The Risks Of Investing In Aurinia Pharmaceuticals Inc (AUPH) - Knox Daily

Feb 10, 2025

Feb 07, 2025